Level C· Early human research exploring benefitsCase Report / SeriesEurope PMCOpen access

Acute Onset of Mesoamerican Nephropathy in a Patient With Chronic Gout and Occupational Exposure: A Case Report

Korchnoy I., Jimenez Garcia JG., Izquierdo-Pretel G.

Case Report / Series on Chronic Kidney Disease, Chronic Inflammation, published in Cureus (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
Cureus (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40255749
PMCID
PMC12007439
DOI
10.7759/cureus.80820

Abstract (original English)

Mesoamerican nephropathy (MeN) is a form of chronic kidney disease that is becoming increasingly prevalent. Multiple risk factors, including male gender, exposure to pesticides, heat stress, use of nephrotoxic medications, and a geographical association with Central America, have been linked to this condition. We present the case of a 40-year-old male from El Salvador who sought medical attention due to abnormal laboratory results and a flare-up of gout. The patient exhibited elevated creatinine and blood urea nitrogen (BUN) levels, with a significantly reduced glomerular filtration rate (GFR). His renal function had been stable three months earlier, when he had established care with his primary care physician. The patient had a history of agricultural work in El Salvador, along with long-term use of colchicine and nonsteroidal anti-inflammatory drugs (NSAIDs) for gout flare-ups. Following consultation with nephrology, he was diagnosed with MeN due to his relevant risk factors and clinical presentation. This case highlights the acute onset of MeN in a patient with established risk factors.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research